Moreover, it is hypothesized that galectin-3, mainly derived from macrophages and the adipokine adiponectin, might promisingly participate in the “cross-talk” of macrophages and adipocytes, serving as a new diabetic target by functioning together with insulin resistance and inflammation [26, 27]. The gene discussed is ADIPOQ; the disease is Insulin resistance.